Colorectal cancer is the third most common cancer and second leading cause of cancer death in the United States, with approximately 153,020 new cases and 52,550 deaths expected annually. Nearly 60% of diagnoses occur in adults aged 65 and older, where incidence runs 4-5 times higher than in the 45-54 age group. Survival exceeds 90% for localized disease and falls to approximately 15% for distant-stage presentation, making accurate recognition, timely screening, and complete documentation across the full care continuum among the highest-value clinical actions a primary care team can take.
AAVBC's Colorectal Cancer Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 coding specificity, disease staging, MMR/MSI and biomarker testing requirements, MEAT documentation standards, colonoscopy and multi-modality screening criteria, therapy escalation, survivorship coding, and comorbidity management. Grounded in 2025 USPSTF, ACG, and ACS guideline evidence, this guide supports consistent, individualized clinical decision-making, helping care teams identify colorectal cancer earlier, document disease complexity accurately, and coordinate care with the continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of colorectal cancer — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Colorectal cancer is the third most common cancer and second leading cause of cancer death in the United States, with approximately 153,020 new cases and 52,550 deaths expected annually. Nearly 60% of diagnoses occur in adults aged 65 and older, where incidence runs 4-5 times higher than in the 45-54 age group. Survival exceeds 90% for localized disease and falls to approximately 15% for distant-stage presentation, making accurate recognition, timely screening, and complete documentation across the full care continuum among the highest-value clinical actions a primary care team can take.
AAVBC's Colorectal Cancer Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 coding specificity, disease staging, MMR/MSI and biomarker testing requirements, MEAT documentation standards, colonoscopy and multi-modality screening criteria, therapy escalation, survivorship coding, and comorbidity management. Grounded in 2025 USPSTF, ACG, and ACS guideline evidence, this guide supports consistent, individualized clinical decision-making, helping care teams identify colorectal cancer earlier, document disease complexity accurately, and coordinate care with the continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of colorectal cancer — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
